The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.41BCNY
506.34M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
1.95BCNY
289.13M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-22.27%
vs Publishing peers
Updated Aug 20, 2026
Beta
0.4390x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-28.43%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
3.41BCNY
506.34M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
2.15BCNY
319.18M · vs all stocks (USD)
Updated Aug 20, 2026
Forward P/E
9.18x
vs Publishing peers
Updated Aug 20, 2026
Price to Sales (TTM)
1.74x
vs Publishing peers
Updated Aug 20, 2026
Price to Book (MRQ)
1.23x
vs Publishing peers
Updated Aug 20, 2026
Enterprise to Revenue
1.10x
vs Publishing peers
Updated Aug 20, 2026
Enterprise to EBITDA
-31.35x
vs Publishing peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 49.43×.Updated Aug 20, 2026
Gross Margin
29.71%
vs Publishing peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 18.08%.Updated Aug 20, 2026
Profit Margin
-22.27%
vs Publishing peers
Updated Aug 20, 2026
Operating Margin
16.81%
vs Publishing peers
Updated Aug 20, 2026
Return on Assets (TTM)
-2.26%
vs Publishing peers
Updated Aug 20, 2026
Return on Equity (TTM)
-14.38%
vs Publishing peers
Updated Aug 20, 2026
Revenue (TTM)
1.95BCNY
289.13M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
2.94CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-6.10%
vs Publishing peers
Updated Aug 20, 2026
Gross Profit (TTM)
352.06MCNY
52.29M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
43.48MCNY
6.46M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-433.47MCNY
-64.38M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-57.70%
vs Publishing peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
174.72MCNY
25.95M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
158.79MCNY
23.58M · vs all stocks (USD)
Updated Aug 20, 2026
5-Year Average Dividend Yield
2.45%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
289.39%
vs Publishing peers
Updated Aug 20, 2026
Minority Interest (Equity)
10.84MCNYFY2025 · Dec 31, 2025
Revenue
1.98BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.55BCNYFY2025 · Dec 31, 2025
Gross Profit
435.19MCNYFY2025 · Dec 31, 2025
Operating Income
-49.78MCNY
-7.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-397.43MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-233.42KCNYFY2025 · Dec 31, 2025
Net Income
-397.20MCNYFY2025 · Dec 31, 2025
EBIT
-396.80MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
43.48MCNYFY2025 · Dec 31, 2025
Research & Development
8.33MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
128.13MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
18.06MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
7.00MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
628.73KCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.6000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.6000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
661.65MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
661.65MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-397.20MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
204.52KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-294.25MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-314.66MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.21BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-397.20MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.45MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
12.88MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
82.62MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-20.41MCNYFY2025 · Dec 31, 2025
Sale of Investments
184.90KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-20.22MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
100.00KCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-46.25MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-14.98MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-61.14MCNYFY2025 · Dec 31, 2025
Shares Outstanding
660.71MSharesUpdated Aug 20, 2026
Float Shares
237.27MSharesUpdated Aug 20, 2026
% Held by Insiders
64.58%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
1.17%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
1.20BCNY
178.89M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
1.82CNYUpdated Aug 20, 2026
Total Debt (MRQ)
13.02MCNY
1.93M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.0047x
vs Publishing peers
Updated Aug 20, 2026
Current Ratio (MRQ)
2.40x
vs Publishing peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
4.18CNYUpdated Aug 20, 2026
Total Assets
3.75BCNY
557.19M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.30BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.00BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.45BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
22.78MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
981.31MCNYFY2025 · Dec 31, 2025
Cash
1.20BCNYFY2025 · Dec 31, 2025
Cash Equivalents
48.18MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.25BCNYFY2025 · Dec 31, 2025
Accounts Receivable
446.83MCNYFY2025 · Dec 31, 2025
Inventory
514.96MCNYFY2025 · Dec 31, 2025
Accounts Payable
581.91MCNYFY2025 · Dec 31, 2025
Short-term Debt
8.26MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
14.35MCNYFY2025 · Dec 31, 2025
Long-term Debt
8.99MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.66MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
660.71MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.63BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.75BCNY
408.06M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
4.56CNYUpdated Aug 20, 2026
52-Week High
7.29CNYUpdated Aug 20, 2026
52-Week Change
-28.43%
vs all stocks
Updated Aug 20, 2026
Beta
0.4390x
vs all stocks
Updated Aug 20, 2026
50-Day MA
5.00CNYUpdated Aug 20, 2026
200-Day MA
6.04CNYUpdated Aug 20, 2026
Avg 10-Day Volume
3.50MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
4.83MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-0.6600CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.25: safe zoneNotable
Altman Z-Score: 3.25
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Levered free cash flow is $23.58M, above the global median of $16.24MNotable